Tyrosine Kinase Inhibitors with or without Donor Lymphocyte Infusion Continue to Provide Long-Term Survival after Relapse of Chronic Myeloid Leukemia Following Hematopoietic Cell Transplantation

被引：1
|
作者：
Schmidt, Sarah Ann [1 ]
Chakrabarty, Jennifer Holter [2 ]
Liu, Ying [3 ,4 ]
Hu, Zhen-Huan [3 ]
Williams, Kirsten M. [5 ]
Alyea, Edwin P., III [6 ]
Popat, Uday [7 ]
Sobecks, Ronald [8 ]
Scott, Bart L.
Saber, Wael [3 ]
机构：
[1] Univ Oklahoma, Oklahoma City, OK USA
[2] Univ Oklahoma, Dept Hematol Oncol, Oklahoma City, OK USA
[3] Med Coll Wisconsin, Dept Med, CIBMTR, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Div Biostat, Inst Hlth & Soc, Milwaukee, WI 53226 USA
[5] Childrens Natl Med Ctr, CETI, Washington, DC 20010 USA
[6] Dana Farber Canc Inst, Ctr Hematol Oncol, Boston, MA 02115 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[8] Cleveland Clin Fdn, Dept Hematol & Med Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-118918
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
704
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Challenges for Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
    Oyekunle, Anthony
    Klyuchnikov, Evgeny
    Ocheni, Sunday
    Kroeger, Nicolaus
    Zander, Axel R.
    Baccarani, Michele
    Bacher, Ulrike
    ACTA HAEMATOLOGICA, 2011, 126 (01) : 30 - 39
  • [22] Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    XU Lan-ping
    HUANG Xiao-jun
    中华医学杂志（英文版）, 2013, 126 (04) : 768 - 774
  • [23] Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Xu Lan-ping
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 768 - 774
  • [24] Long-term survival benefit after allogeneic hematopoietic cell transplantation in chronic myelomonocytic leukemia
    Gagelmann, N.
    Bogdanov, R.
    Stoelzel, F.
    Rautenberg, C.
    Becker, H.
    Radujkovic, A.
    Panagiota, V.
    Finke, J.
    Kobbe, G.
    Luft, T.
    Platzbecker, U.
    Heuser, M.
    Schroeder, T.
    Koldehoff, M.
    Christopeit, M.
    Beelen, D.
    Germing, U.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 170 - 170
  • [25] Contemporary role of maintenance tyrosine kinase inhibitors following allogeneic hematopoietic cell transplantation for chronic myeloid leukemia: a CIBMTR analysis
    DeFilipp, Zachariah
    Ancheta, Richard
    Liu, Ying
    Ahn, Kwang Woo
    Hu, Zhen Huan
    Alyea, Edwin
    Popat, Uday
    Sobecks, Ronald
    Saber, Wael
    BONE MARROW TRANSPLANTATION, 2018, 53 : 51 - 52
  • [26] Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia
    Gagelmann, Nico
    Bogdanov, Rashit
    Stoelzel, Friedrich
    Rautenberg, Christina
    Panagiota, Victoria
    Becker, Heiko
    Radujkovic, Aleksandar
    Luft, Thomas
    Christopeit, Maximilian
    Finke, Jurgen
    Platzbecker, Uwe
    Ditschkowski, Markus
    Schroeder, Thomas
    Koldehoff, Michael
    Heuser, Michael
    Kobbe, Guido
    Beelen, Dietrich W.
    Germing, Ulrich
    Kroeger, Nicolaus
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (01):
  • [27] Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation
    Helg, C
    Starobinski, M
    Jeannet, M
    Chapuis, B
    LEUKEMIA & LYMPHOMA, 1998, 29 (3-4) : 301 - 313
  • [28] LONG-TERM SURVIVAL OF PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITORS THERAPY AFTER INTERFERON-ALFA FAILURE
    Lazareva, O. V.
    Gusarova, G. A.
    Chelysheva, E. Y.
    Bykova, A.
    Shukhov, O. A.
    Zakharova, E. S.
    Kolosheinova, T. I.
    Kuznetsov, S. V.
    Tishchenko, I. A.
    Kulikov, S. M.
    Turkina, A. G.
    HAEMATOLOGICA, 2014, 99 : 604 - 605
  • [29] Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571
    Baron, F
    Frère, P
    Fillet, G
    Beguin, Y
    HAEMATOLOGICA, 2001, 86 (09) : 993 - 994
  • [30] Tyrosine Kinase Inhibitors and Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia: Targeting Both Therapeutic Modalities
    Fernandez, Hugo F.
    Kharfan-Dabaja, Mohamed A.
    CANCER CONTROL, 2009, 16 (02) : 153 - 157
12345